Back | Next |
home / stock / srpt / srpt message board
Subject | By | Source | When |
---|---|---|---|
The trading | girlfriend | investorshub | 04/20/2023 8:07:49 AM |
The trading | girlfriend | investorshub | 04/18/2023 6:27:36 PM |
Price now | girlfriend | investorshub | 04/18/2023 5:44:53 PM |
$SRPT what does this mean? | Atown62 | investorshub | 04/17/2023 11:49:28 PM |
The trading last up | Myth | investorshub | 04/17/2023 7:27:35 PM |
$SRPT Have a look at this | Atown62 | investorshub | 04/16/2023 9:31:15 AM |
$SRPT news out | Atown62 | investorshub | 04/15/2023 8:41:44 AM |
whytestocks: $SRPT News Article - 2 Top Growth Stocks That Could Soar This Spring | whytestocks | investorshangout | 04/06/2023 5:15:46 PM |
whytestocks: $SRPT News Article - Sarepta Therapeutics Announces Initiation of VOYAGENE, a Clinical | whytestocks | investorshangout | 02/17/2023 6:45:47 PM |
whytestocks: $SRPT News Article - Sarepta Therapeutics Submits Biologics License Application for SRP | whytestocks | investorshangout | 09/29/2022 4:20:50 PM |
Go$ SRPT , buyout $AMLX | sorkin | investorshub | 09/08/2022 9:43:59 PM |
looking to get some $SRPT call options | TheFinalCD | investorshub | 08/19/2022 5:53:37 PM |
Thankful I didn't sell all my shares. | girlfriend | investorshub | 08/01/2022 12:15:52 PM |
Good stuff | Atown62 | investorshub | 08/01/2022 12:31:43 AM |
whytestocks: $SRPT News Article - Sarepta Therapeutics Provides Update on SRP-5051 for the Treatment | whytestocks | investorshangout | 06/23/2022 8:55:51 PM |
Indeed. Wish I had more shares but this | girlfriend | investorshub | 04/08/2022 12:30:57 AM |
Trend is UP | Atown62 | investorshub | 04/07/2022 11:35:51 PM |
. | Atown62 | investorshub | 03/29/2022 2:29:08 AM |
Thank you! | girlfriend | investorshub | 03/22/2022 11:18:55 AM |
https://musculardystrophynews.com/2022/03/21/mda-2022-dmd-boys-improved-walking- | Atown62 | investorshub | 03/22/2022 3:20:36 AM |
News, Short Squeeze, Breakout and More Instantly...
Sarepta Therapeutics Inc. Company Name:
SRPT Stock Symbol:
NASDAQ Market:
Sarepta Therapeutics Inc. Website:
Pfizer (NYSE: PFE) announced that a phase III study on its mini-dystrophin gene therapy fordadistrogene movaparvovec for treating Duchenne muscular...
2024-06-13 15:15:01 ET Citigroup analyst issues BUY recommendation for SRPT on June 13, 2024 01:18PM ET. The previous analyst recommendation was Buy. SRPT was trading at $123.865 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current ana...
2024-06-13 11:00:06 ET Brian Skorney from Robert W. Baird issued a price target of $170.00 for SRPT on 2024-06-13 10:14:00. The adjusted price target was set to $170.00. At the time of the announcement, SRPT was trading at $124. The overall price target consensus is at $...